Quanta Therapeutics Stock

Quanta Therapeutics, founded in 2018, is a biopharmaceutical company that creates drugs designed for oncology treatments. The company also develops allosteric modulation aiming to directly restore conformational control of active RAS signaling at the cell membrane, with the goal of inhibiting the full scope of RAS-driven cancer types, thereby enabling researchers to break the resistance paradigms of targeted therapy in oncology. Quanta Therapeutics is headquartered in San Francisco, California.